Cargando…
Analysis of State-Level Drug Pricing Transparency Laws in the United States
This cross-sectional study examines state drug pricing transparency laws enacted to increase supply chain price transparency in the United States.
Autores principales: | Ryan, Martha S., Sood, Neeraj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6763978/ https://www.ncbi.nlm.nih.gov/pubmed/31553467 http://dx.doi.org/10.1001/jamanetworkopen.2019.12104 |
Ejemplares similares
-
Correlates of Price Transparency for Healthcare Services in United States Hospitals
por: Younessi, David N, et al.
Publicado: (2022) -
Mohs Surgery Price Transparency and Variability at Academic Hospitals After the Implementation of the Federal Price Transparency Final Rule
por: Jain, Neelesh P, et al.
Publicado: (2023) -
Use Patterns of a State Health Care Price Transparency Web Site: What Do Patients Shop For?
por: Mehrotra, Ateev, et al.
Publicado: (2014) -
Transparency, Accessibility, and Variability of US Hospital Price Data
por: Haque, Waqas, et al.
Publicado: (2021) -
Characteristics of State Legislation Addressing Prescription Drug Price Increases in the United States, 2020
por: Shahriar, Arman A., et al.
Publicado: (2021)